myristic acid has been researched along with thapsigargin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andersson, LC; Lindqvist, C; Mustelin, T; Nordström, T; Ståhls, A | 1 |
| Cooper, DM; Fagan, KA; Li, KX; Lin, S; Rodman, DM; Shaul, PW | 1 |
2 other study(ies) available for myristic acid and thapsigargin
| Article | Year |
|---|---|
Inhibition of CD3-induced Ca2+ signals in Jurkat T-cells by myristic acid.
Topics: Antigens, Differentiation, T-Lymphocyte; Calcium; CD3 Complex; Cell Division; Humans; Lauric Acids; Muromonab-CD3; Myristic Acid; Myristic Acids; Receptors, Antigen, T-Cell; Signal Transduction; T-Lymphocytes; Terpenes; Thapsigargin; Tumor Cells, Cultured | 1991 |
Sustained endothelial nitric-oxide synthase activation requires capacitative Ca2+ entry.
Topics: Aequorin; Animals; Calcium; COS Cells; Endothelium, Vascular; Enzyme Activation; Enzyme Inhibitors; Histamine; Ionomycin; Luminescent Measurements; Myristic Acid; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Recombinant Proteins; Thapsigargin; Transfection | 2000 |